Podrobno

MicroRNAs as biomarkers in spinal muscular atrophy
ID Barbo, Maruša (Avtor), ID Glavač, Damjan (Avtor), ID Jezernik, Gregor (Avtor), ID Ravnik-Glavač, Metka (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,03 MB)
MD5: C6F1D11CB9A697465E6D178834329190
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2227-9059/12/11/2428 Povezava se odpre v novem oknu

Izvleček
Spinal muscular atrophy (SMA) is a severe neurodegenerative disease caused by the loss of the survival motor neuron (SMN) protein, leading to degeneration of anterior motor neurons and resulting in progressive muscle weakness and atrophy. Given that SMA has a single, well-defined genetic cause, gene-targeted therapies have been developed, aiming to increase SMN production in SMA patients. The SMN protein is likely involved in the synthesis of microRNAs (miRNAs), and dysregulated miRNA expression is increasingly associated with the pathophysiology of SMA. Currently, there is a lack of reliable biomarkers to monitor SMA; therefore, the search for novel SMA biomarkers, including miRNAs, is crucial as reliable tools are needed to track disease progression, predict the response to therapy and understand the different clinical outcomes of available treatments. In this review, we compile data on miRNAs associated with SMA pathogenesis and their potential use as biomarkers. Based on current knowledge, the most frequently deregulated miRNAs between SMA patients and controls, as well as pre- and post-treatment in SMA patients, include miR-1-3p, miR-133a-3p, miR-133b, and miR-206. These findings offer promising possibilities for improving patient classification and monitoring disease progression and response to treatment. Additionally, these findings provide insights into the broader molecular mechanisms and networks of SMA that could inform the development of future therapeutic strategies.

Jezik:Angleški jezik
Ključne besede:spinal muscular atrophy, SMA, circulating miRNA, biomarkers, molecular networks
Vrsta gradiva:Članek v reviji
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:16 str.
Številčenje:Vol. 12, iss. 11, art. 2428
PID:20.500.12556/RUL-176039 Povezava se odpre v novem oknu
UDK:577
ISSN pri članku:2227-9059
DOI:10.3390/biomedicines12112428 Povezava se odpre v novem oknu
COBISS.SI-ID:214140931 Povezava se odpre v novem oknu
Datum objave v RUL:19.11.2025
Število ogledov:89
Število prenosov:35
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Biomedicines
Skrajšan naslov:Biomedicines
Založnik:MDPI
ISSN:2227-9059
COBISS.SI-ID:523006745 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:spinalna mišična atrofija, SMA, cirkulirajoča miRNA, biološki označevalci, molekularne mreže

Projekti

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P1-0170
Naslov:Molekulski mehanizmi uravnavanja celičnih procesov v povezavi z nekaterimi boleznimi pri človeku

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Program financ.:Young researchers

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj